BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND Neurokinin
6 results:

  • 1. neurokinin-1 receptor is highly expressed in cervical cancer and its antagonist induces cervical cancer cell apoptosis.
    Guan L; Yuan S; Ma J; Liu H; Huang L; Zhang F
    Eur J Histochem; 2023 Jan; 67(1):. PubMed ID: 36629320
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Control and Risk Factors of Nausea and Vomiting in Patients With cervical cancer Receiving Radiotherapy.
    Uno A; Yamamoto S; Iihara H; Fujii H; Makita C; Hayasaki Y; Ueda Y; Ito M; Takenaka M; Kumano T; Mori M; Yasue M; Kato-Hayashi H; Kobayashi R; Morishige KI; Matsuo M; Hayashi H; Suzuki A
    Anticancer Res; 2022 Jun; 42(6):3117-3123. PubMed ID: 35641271
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
    Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
    Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prescription of Prophylactic Antiemetic Drugs for Patients Receiving Chemotherapy With Minimal and Low Emetic Risk.
    Okuyama A; Nakamura F; Higashi T
    JAMA Oncol; 2017 Mar; 3(3):344-350. PubMed ID: 27812688
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial.
    Ruhlmann CH; Christensen TB; Dohn LH; Paludan M; Rønnengart E; Halekoh U; Hilpert F; Feyer P; Kristensen G; Hansen O; Keefe D; Herrstedt J
    Lancet Oncol; 2016 Apr; 17(4):509-518. PubMed ID: 26952945
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Addition of the neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin.
    Jahn F; Riesner A; Jahn P; Sieker F; Vordermark D; Jordan K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1101-1107. PubMed ID: 26059352
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.